CP-122,288 (original) (raw)

About DBpedia

CP-122,288 is a drug which acts as a potent and selective agonist for the 5-HT1B, 5-HT1D and 5-HT1F serotonin receptor subtypes. It is a derivative of the migraine medication sumatriptan, but while CP-122,288 is 40,000 times more potent than sumatriptan as an inhibitor of neurogenic inflammation and plasma protein extravasation, it is only twice as potent as a constrictor of blood vessels. In human trials, CP-122,288 was not found to be effective as a treatment for migraine, but its selectivity for neurogenic anti-inflammatory action over vasoconstriction has made it useful for research into the underlying causes of migraine.

thumbnail

Property Value
dbo:abstract CP-122,288 is a drug which acts as a potent and selective agonist for the 5-HT1B, 5-HT1D and 5-HT1F serotonin receptor subtypes. It is a derivative of the migraine medication sumatriptan, but while CP-122,288 is 40,000 times more potent than sumatriptan as an inhibitor of neurogenic inflammation and plasma protein extravasation, it is only twice as potent as a constrictor of blood vessels. In human trials, CP-122,288 was not found to be effective as a treatment for migraine, but its selectivity for neurogenic anti-inflammatory action over vasoconstriction has made it useful for research into the underlying causes of migraine. (en)
dbo:casNumber 143321-74-8
dbo:fdaUniiCode 59E9WCT6EM
dbo:pubchem 132552
dbo:thumbnail wiki-commons:Special:FilePath/CP-122,288_Structure.svg?width=300
dbo:wikiPageID 46919927 (xsd:integer)
dbo:wikiPageLength 4333 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID 1107937269 (xsd:integer)
dbo:wikiPageWikiLink dbc:5-HT1B_agonists dbc:Amines dbc:Pyrrolidines dbc:Tryptamines dbr:Eletriptan dbr:CP-135807 dbr:5-MeO-MPMI dbr:Agonist dbc:5-HT1D_agonists dbc:5-HT1F_agonists dbr:Sumatriptan dbr:Migraine dbr:Serotonin_receptor dbr:5-HT1B dbr:5-HT1D dbr:5-HT1F
dbp:c 16 (xsd:integer)
dbp:casNumber 143321 (xsd:integer)
dbp:chemspiderid 117032 (xsd:integer)
dbp:h 23 (xsd:integer)
dbp:iupacName N-methyl-1-[3--1H-indol-5-yl]methanesulfonamide (en)
dbp:iupharLigand 110 (xsd:integer)
dbp:n 3 (xsd:integer)
dbp:o 2 (xsd:integer)
dbp:pubchem 132552 (xsd:integer)
dbp:s 1 (xsd:integer)
dbp:smiles CNSCc1ccc2ccC[C@H]3CCCN3C (en)
dbp:stdinchi 1 (xsd:integer)
dbp:stdinchikey BWQZTHPHLITOOZ-CQSZACIVSA-N (en)
dbp:unii 59000000000 (xsd:decimal)
dbp:width 220 (xsd:integer)
dbp:wikiPageUsesTemplate dbt:Drugbox dbt:Nervous-system-drug-stub dbt:Reflist dbt:Serotonin_receptor_modulators dbt:Short_description dbt:Cascite dbt:Fdacite
dcterms:subject dbc:5-HT1B_agonists dbc:Amines dbc:Pyrrolidines dbc:Tryptamines dbc:5-HT1D_agonists dbc:5-HT1F_agonists
gold:hypernym dbr:Drug
rdf:type owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:Drug
rdfs:comment CP-122,288 is a drug which acts as a potent and selective agonist for the 5-HT1B, 5-HT1D and 5-HT1F serotonin receptor subtypes. It is a derivative of the migraine medication sumatriptan, but while CP-122,288 is 40,000 times more potent than sumatriptan as an inhibitor of neurogenic inflammation and plasma protein extravasation, it is only twice as potent as a constrictor of blood vessels. In human trials, CP-122,288 was not found to be effective as a treatment for migraine, but its selectivity for neurogenic anti-inflammatory action over vasoconstriction has made it useful for research into the underlying causes of migraine. (en)
rdfs:label CP-122,288 (en)
owl:sameAs yago-res:CP-122,288 wikidata:CP-122,288 https://global.dbpedia.org/id/y3rG
prov:wasDerivedFrom wikipedia-en:CP-122,288?oldid=1107937269&ns=0
foaf:depiction wiki-commons:Special:FilePath/CP-122,288_Structure.svg
foaf:isPrimaryTopicOf wikipedia-en:CP-122,288
is dbo:wikiPageRedirects of dbr:C16H23N3O2S
is dbo:wikiPageWikiLink of dbr:C16H23N3O2S dbr:5-HT1B_receptor
is foaf:primaryTopic of wikipedia-en:CP-122,288